AIT Bioscience, LLC

15 articles about AIT Bioscience, LLC

• Nexelis Acquires Integrated Bioanalytical CRO AIT Bioscience

  7/22/2020

   Nexelis, a portfolio company of Ampersand Capital Partners and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and metabolic diseases fields, is pleased to announce its acquisition of AIT Bioscience.

• AIT Bioscience Names New CEO, Jeff Goddard

  10/14/2019

  AIT Bioscience, a bioanalytical contract research organization (CRO) that is part of Indiana's life sciences hub, announces Jeff Goddard, MBA, as the new Chief Executive Officer (CEO) and member of the AIT Bioscience Board of Directors

• AIT Bioscience Celebrates 10 Year Anniversary

  6/28/2019

  AIT Bioscience, a bioanalytical contract research organization (CRO) that is a member of Indiana's life sciences hub, is celebrating its 10-year anniversary.

• AIT Bioscience’s Terri Pascarelli Recognized as a 2018 PharmaVOICE 100 honoree

  8/3/2018

  AIT Bioscience, LLC Chief Executive Officer, Terri Pascarelli has been named among the 2018 PharmaVOICE 100 honorees.

• AIT Bioscience Welcomes New Scientist, Jim Eckstein

  1/19/2018

  AIT Bioscience welcomes Jim Eckstein to our scientific ranks. Jim brings more than 20 years of experience in LC/MS analysis, including the analysis of small molecule pharmaceuticals, biomarkers, as well as peptide and protein biotherapeutics.

• Healthcare Businesswomen's Association Names AIT Bioscience CEO Terri Pascarelli as Recipient of its Annual Strategic Transformation Achievement Recognition Award

  1/10/2018

  As a company that prides itself on its experienced scientific and business professionals, AIT Bioscience is pleased to announce that the company’s CEO, Terri Pascarelli, has been recognized with the STAR award by HBA.

• Local and National Organizations Benefit From AIT Bioscience CEO's Leadership

  12/22/2017

  The Vanguard Forum for Healthcare Leaders invited AIT Bioscience CEO Terri Pascarelli to serve as a faculty member at its November 2017 event in New York City, NY.

• AIT Bioscience Employees Present at i3 North American Community Forum

  11/12/2017

  In early October, two AIT Bioscience employees, April Pisek and Jessica White, presented at the i3 North American Community Forum in Seattle, Washington at the request of IDBS.

• AIT Bioscience Welcomes New Chief Scientific Officer

  8/30/2017

  Anderson replaces Ronald E. Shoup, Ph.D. in this role.

• AIT Bioscience Among Inc.'s 5000 Fastest Growing Private Companies

  8/16/2017

  The list represents a unique look at the most successful companies within the American economy's most dynamic segment.

• American Society of Mass Spectrometry in Indy

  6/20/2017

  From June 4-8, the city of Indianapolis had the privilege of playing host to nearly 6500 scientists from around the world who gathered to discuss all aspects of using mass spectrometry in a wide variety of applications.

• AIT Bioscience Attends Bio+Tech17 and AAPS NBC Conferences

  5/22/2017

  AIT Biosciences recently attended the Bio+Tech17 Conference in Bethesda, Maryland from April 27-28, 2017 and the AAPS NBC Conference in San Diego, California from May 1-3, 2017.

• AIT Bioscience Recognized with Awards at Recent WRIB

  5/18/2017

  WRIB (Workshop for Recent Issues in Bioanalysis) is an annual gathering of bioanalytical scientists from across the pharmaceutical industry spectrum.

• AIT Bioscience Offers New Screening Level Assay

  1/30/2017

  A fit-for-purpose approach to bioanalytical assay support balances intended use of data with regulatory requirements and budgets.

• AIT Bioscience Names Terri Pascarelli As New CEO

  4/16/2015